Abbott's FreeStyle ® Libre 14 Day System Now Available in U.S. for Hospitalized Patients with Diabetes During COVID-19 Pandemic
-- More than 50% of people with diabetes who have been diagnosed with COVID-19 are hospitalized, according to a report from the Centers for Disease Control and Prevention (CDC) ¹ (Source: Abbott.com)
Source: Abbott.com - April 8, 2020 Category: Pharmaceuticals Source Type: news

Abbott Launches Molecular Point-of-Care Test to Detect Novel Coronavirus in as Little as Five Minutes
- The Abbott ID NOW ™ COVID-19 test brings rapid testing to the front lines (Source: Abbott.com)
Source: Abbott.com - March 28, 2020 Category: Pharmaceuticals Source Type: news

Abbott Hosts Conference Call for First-Quarter Earnings
(Source: Abbott.com)
Source: Abbott.com - March 19, 2020 Category: Pharmaceuticals Source Type: news

Abbott Receives FDA Emergency Use Authorization and Launches Test to Detect Novel Coronavirus
- The test will be used on the company's m2000 RealTime system that is currently available in hospitals and molecular laboratories in the U.S. (Source: Abbott.com)
Source: Abbott.com - March 18, 2020 Category: Pharmaceuticals Source Type: news

Abbott Aims to Optimize TAVI Implants with European Approval of FlexNav ™ Delivery System for the Company's Portico™ Valve
- New FlexNav ™ delivery system improves control and delivery of the Portico™ TAVI valve even in complex clinical cases (Source: Abbott.com)
Source: Abbott.com - March 5, 2020 Category: Pharmaceuticals Source Type: news

Abbott Declares 385th Consecutive Quarterly Dividend
(Source: Abbott.com)
Source: Abbott.com - February 21, 2020 Category: Pharmaceuticals Source Type: news

New Real-World Data Show that Abbott's FreeStyle Libre System Delivers Positive Health Outcomes for People with Type 1 and Type 2 Diabetes
- Data at ATTD reinforce and add to a growing body of clinical research and real-world evidence from users of the FreeStyle Libre system around the world (Source: Abbott.com)
Source: Abbott.com - February 20, 2020 Category: Pharmaceuticals Source Type: news

Abbott and Insulet Partner to Integrate Next-Generation Glucose Sensing and Automated Insulin Delivery Technologies for Seamless Diabetes Care
- Collaboration will combine Abbott's leading continuous glucose monitoring (CGM) technology with Insulet's Omnipod Horizon ™ Automated Insulin Delivery System to offer an accurate, easy-to-use, integrated digital health platform (Source: Abbott.com)
Source: Abbott.com - February 19, 2020 Category: Pharmaceuticals Source Type: news

Abbott Introduces Next-Generation Heart Rhythm Management Devices in Europe, Featuring State-of-the-Art Patient App and Bluetooth Connectivity
- New Gallant ™ high voltage devices offer patients and their doctors a smartphone app and Bluetooth connectivity designed to help doctors tailor therapy to a patient's unique clinical needs (Source: Abbott.com)
Source: Abbott.com - February 18, 2020 Category: Pharmaceuticals Source Type: news

Abbott's In-Development Fully Implantable Heart Pump System Earns FDA's Breakthrough Device Designation
(Source: Abbott.com)
Source: Abbott.com - February 4, 2020 Category: Pharmaceuticals Source Type: news

Abbott Announces First-of-Its-Kind Trial to Assess New Therapy Option for People at Risk of Stroke
- The CATALYST trial will examine Abbott's Amplatzer ™ Amulet™ device compared to non-vitamin K oral anticoagulants, the current standard in attempting to lower stroke and bleeding risks for patients with atrial fibrillation (Source: Abbott.com)
Source: Abbott.com - February 3, 2020 Category: Pharmaceuticals Source Type: news

Abbott's Tendyne ™ Device Receives World's First CE Mark for Transcatheter Mitral Valve Implantation
- First-of-its-kind technology addresses critical need to eliminate mitral regurgitation when surgery or mitral repair is not an option (Source: Abbott.com)
Source: Abbott.com - January 30, 2020 Category: Pharmaceuticals Source Type: news

Abbott Receives Expanded Indication From the U.S. FDA for Directional Deep Brain Stimulation System to Treat Parkinson's Disease
- Abbott's Infinity ™ DBS is the first FDA approved directional Deep Brain Stimulation (DBS) system to allow targeting of a specific area of the brain that is critical to motor functions (Source: Abbott.com)
Source: Abbott.com - January 24, 2020 Category: Pharmaceuticals Source Type: news

New Quality of Life and Functional Improvement Data From Abbott's BOLD and TRIUMPH Studies Reinforce Benefit of Proclaim ™ XR Neurostimulation System In People Living with Chronic Pain
- BOLD study found that BurstDR ™ stimulation waveform reduced the negative psychological effects associated with a person's chronic pain at six-month follow up by 62% (Source: Abbott.com)
Source: Abbott.com - January 23, 2020 Category: Pharmaceuticals Source Type: news

Abbott Reports Fourth-Quarter 2019 Results; Announces Strong Forecast for 2020
- Fourth-quarter sales growth of 7.1 percent; organic sales growth of 8.5 percent (Source: Abbott.com)
Source: Abbott.com - January 22, 2020 Category: Pharmaceuticals Source Type: news

Abbott to Initiate Trial to Study MitraClip as an Option for Moderate Surgical Risk Patients
- New clinical trial will assess first-of-its-kind MitraClip ™ transcatheter mitral valve repair against current standard of care surgery in a new, expanded patient population (Source: Abbott.com)
Source: Abbott.com - January 13, 2020 Category: Pharmaceuticals Source Type: news

FDA Approves Less Invasive Surgical Approach for Abbott's Heart Pump to Help Patients Avoid Open Heart Surgery
- For people battling advanced heart failure, Abbott's HeartMate 3 heart pump can now be implanted through an incision in the chest wall versus open heart surgery (Source: Abbott.com)
Source: Abbott.com - January 7, 2020 Category: Pharmaceuticals Source Type: news

Abbott Hosts Conference Call for Fourth-Quarter Earnings
(Source: Abbott.com)
Source: Abbott.com - January 2, 2020 Category: Pharmaceuticals Source Type: news

Abbott Raises Quarterly Dividend 12.5%, Increasing Payouts for 48 Straight Years
(Source: Abbott.com)
Source: Abbott.com - December 13, 2019 Category: Pharmaceuticals Source Type: news

Abbott Announces Robert B. Ford to Succeed Miles D. White as Chief Executive Officer on March 31, 2020
- Mr. White will remain Executive Chairman of the Board (Source: Abbott.com)
Source: Abbott.com - November 13, 2019 Category: Pharmaceuticals Source Type: news

Abbott Announces Discovery of New Strain of HIV, Keeping Global Health Community a Step Ahead of the Virus
- Discovery marks the first time a new subtype of HIV-1 has been identified since 2000 (Source: Abbott.com)
Source: Abbott.com - November 6, 2019 Category: Pharmaceuticals Source Type: news

Americans Are Concerned About Road Safety as More States Legalize Recreational Cannabis, New Survey Finds
- One-third of Americans have heard someone say: "I drive better when I've smoked marijuana" (Source: Abbott.com)
Source: Abbott.com - October 22, 2019 Category: Pharmaceuticals Source Type: news

The Australian Red Cross Blood Service Selects Abbott's Alinity s Solution for Blood and Plasma Screening
Abbott and the Australian Red Cross Blood Service extend 30-year partnership of providing safe, life-saving blood supply in Australia (Source: Abbott.com)
Source: Abbott.com - October 21, 2019 Category: Pharmaceuticals Source Type: news

Abbott Reports Third-Quarter 2019 Results
- Third-quarter sales growth of 5.5 percent; organic sales growth of 7.6 percent (Source: Abbott.com)
Source: Abbott.com - October 16, 2019 Category: Pharmaceuticals Source Type: news

Canadians Indicate Growing Concern About Road Safety at One-Year Anniversary of Recreational Cannabis Legalization, New Survey Finds
-- Oct. 17, 2019, marks the one-year anniversary of legalized recreational cannabis nationwide (Source: Abbott.com)
Source: Abbott.com - October 15, 2019 Category: Pharmaceuticals Source Type: news

Abbott and Tandem Diabetes Care Exploring New Integrated Solutions to Improve Diabetes Management
- Companies aim to integrate Abbott's FreeStyle Libre glucose sensing technology with Tandem's insulin delivery products to expand choices for people with diabetes (Source: Abbott.com)
Source: Abbott.com - October 15, 2019 Category: Pharmaceuticals Source Type: news

Abbott and Omada Health Partner to Offer Integrated Digital Health and Coaching Experience for People with Type 2 Diabetes
- Collaboration combines Abbott ′s world-leading glucose sensing technology with Omada Health's best-in-class, proprietary digital coaching platform to provide personalized, on-the-go care (Source: Abbott.com)
Source: Abbott.com - October 14, 2019 Category: Pharmaceuticals Source Type: news

Abbott and Abbott Fund Launch 'Future Well Kids' Program to Help Students Shape Healthier Lives
- Abbott volunteers work with teachers to empower students to take charge of their health, adopting healthy habits that last a lifetime (Source: Abbott.com)
Source: Abbott.com - October 7, 2019 Category: Pharmaceuticals Source Type: news

Late-Breaking Data Shows Abbott's MitraClip ™ is Cost Effective, Increases Life Expectancy and Improves Quality of Life
- New late-breaking data at TCT 2019 demonstrate that Abbott's MitraClip ™ is cost-effective for heart failure patients with significant secondary mitral regurgitation compared to guideline-directed medical therapy alone (Source: Abbott.com)
Source: Abbott.com - September 29, 2019 Category: Pharmaceuticals Source Type: news

New Data Demonstrate Strong Outcomes for Abbott Device to Repair Leaky Tricuspid Heart Valves
- New data presented at TCT 2019 on Abbott's TriClip device from the TRILUMINATE Feasibility Study met both the primary safety and performance endpoints (Source: Abbott.com)
Source: Abbott.com - September 29, 2019 Category: Pharmaceuticals Source Type: news

FDA Approves Abbott's "Low Dose," Recharge-Free Spinal Cord Stimulation System with up to Ten Year Battery Life* for People Living with Chronic Pain
- Proclaim ™ XR neurostimulation system uses Abbott's proprietary, low energy BurstDR™ therapy coupled with the BoldXR™ low dosing protocol for safe, effective pain relief and a battery that lasts up to 10 Years* (Source: Abbott.com)
Source: Abbott.com - September 26, 2019 Category: Pharmaceuticals Source Type: news

U.S. FDA Clears Abbott's High Sensitivity Troponin-I Blood Test That Aids Doctors in Diagnosing Heart Attacks Faster and More Accurately
Newly cleared diagnostic test could help identify heart attacks several hours sooner than standard troponin tests and help improve diagnosis in women (Source: Abbott.com)
Source: Abbott.com - September 25, 2019 Category: Pharmaceuticals Source Type: news

Abbott Hosts Conference Call for Third-Quarter Earnings
(Source: Abbott.com)
Source: Abbott.com - September 18, 2019 Category: Pharmaceuticals Source Type: news

Abbott Announces European Approval of Two Life-saving Heart Devices for Babies and Children
- World's smallest pediatric treatments pioneered by Abbott address critical needs for the most vulnerable patients: babies and children born with common congenital heart defects (Source: Abbott.com)
Source: Abbott.com - September 17, 2019 Category: Pharmaceuticals Source Type: news

Abbott Named the Industry Leader in Sustainability for the Seventh Consecutive Year on the Dow Jones Sustainability Index (DJSI)
- Abbott achieves top scores across all three key areas of economic, social and environmental performance, earns more than double the average score in Health Care Equipment& Supplies industry sector (Source: Abbott.com)
Source: Abbott.com - September 16, 2019 Category: Pharmaceuticals Source Type: news

Abbott and Sanofi Partner to Integrate Glucose Sensing and Insulin Delivery Technologies to Help Change the Way Diabetes is Managed
- Collaboration aims to provide a connected device experience for millions of people living with diabetes using insulin (Source: Abbott.com)
Source: Abbott.com - September 16, 2019 Category: Pharmaceuticals Source Type: news

Abbott's Revolutionary FreeStyle ® Libre System Now Reimbursed in the Two Largest Provinces in Canada
(Source: Abbott.com)
Source: Abbott.com - September 13, 2019 Category: Pharmaceuticals Source Type: news

Abbott Declares 383rd Consecutive Quarterly Dividend
(Source: Abbott.com)
Source: Abbott.com - September 12, 2019 Category: Pharmaceuticals Source Type: news

Abbott Announces New Data That Shows Artificial Intelligence Technology Can Help Doctors Better Determine Which Patients are Having a Heart Attack
- New research found Abbott's algorithm created through machine learning could give doctors a more individualized calculation, leveraging factors such as age, sex and the changing dynamics of troponin protein levels in the blood, to improve heart attack diagnosis (Source: Abbott.com)
Source: Abbott.com - September 10, 2019 Category: Pharmaceuticals Source Type: news

Ministry of Health of Rwanda, Society for Family Health Rwanda and Abbott Launch Pioneering Model of Primary Health Care Service Delivery in Rwanda
- New initiative will provide vital primary care services within a 30-minute walk of all Rwandans' homes (Source: Abbott.com)
Source: Abbott.com - September 9, 2019 Category: Pharmaceuticals Source Type: news

He's Back and He's Hydrated: Abbott and NFL Star Odell Beckham Jr. Partner for Pedialyte ®
- Beckham will serve as spokesperson and creative director for Pedialyte (Source: Abbott.com)
Source: Abbott.com - September 6, 2019 Category: Pharmaceuticals Source Type: news

Abbott Launches World's First Pivotal Trial to Test New Approach for Repairing Leaky Tricuspid Heart Valves
- TRILUMINATE Pivotal trial is the world's first randomized clinical trial to evaluate transcatheter tricuspid valve repair in patients with severe tricuspid regurgitation (Source: Abbott.com)
Source: Abbott.com - September 5, 2019 Category: Pharmaceuticals Source Type: news

New Study Finds Abbott's Blood Test Technology Could Help Detect Brain Injury Quickly, Even if CT Scan is Normal
- The TRACK-TBI study found that 64% of people with the highest levels of a protein in the blood were confirmed to have brain injury through an MRI scan, even when a CT scan did not detect it (Source: Abbott.com)
Source: Abbott.com - August 26, 2019 Category: Pharmaceuticals Source Type: news

Together, We Can Increase the Number of Women in STEM: Here is a Tool to Help Companies Get Started
- On Women's Equality Day, Abbott is publishing a blueprint for creating a high school STEM internship aimed at exposing young people, particularly girls, to STEM early and empowering other companies to download and use it (Source: Abbott.com)
Source: Abbott.com - August 26, 2019 Category: Pharmaceuticals Source Type: news

Abbott and Intoximeters Partner to Keep Roads Safer by Bringing Together Industry-leading Technology for Drug and Alcohol Testing
- Agreement gives law enforcement access to the most advanced handheld tools to help detect drug and alcohol-impaired drivers (Source: Abbott.com)
Source: Abbott.com - August 14, 2019 Category: Pharmaceuticals Source Type: news

Abbott Reports Second-Quarter 2019 Results
- Accelerated and sustainable growth driven by strong performance across portfolio (Source: Abbott.com)
Source: Abbott.com - July 17, 2019 Category: Pharmaceuticals Source Type: news

Abbott Receives U.S. Approval of Next-Generation MitraClip ™, Bringing New Enhancements to Abbott's Leading MitraClip Platform
- U.S. approval for MitraClip G4 offers a next-generation approach to mitral valve repair (Source: Abbott.com)
Source: Abbott.com - July 15, 2019 Category: Pharmaceuticals Source Type: news

Abbott Announces FDA Approval of the Alinity ™ s System, the Latest Technology for Screening and Protecting the U.S. Blood and Plasma Supply
- Alinity ™ s System will screen the U.S. blood and plasma supply faster and more efficiently while maintaining highest levels of accuracy (Source: Abbott.com)
Source: Abbott.com - July 11, 2019 Category: Pharmaceuticals Source Type: news

Nutrition Is the Missing Ingredient in Home Health Today, New Study Shows
- Real-world data from Advocate Health Care and Abbott shows prioritizing nutrition care for home health patients helped keep them out of the hospital (Source: Abbott.com)
Source: Abbott.com - June 24, 2019 Category: Pharmaceuticals Source Type: news

Abbott Hosts Conference Call for Second-Quarter Earnings
(Source: Abbott.com)
Source: Abbott.com - June 19, 2019 Category: Pharmaceuticals Source Type: news